Literature DB >> 22451254

Ostomy function after abdominoperineal resection--a clinical and patient evaluation.

E Angenete1, A Correa-Marinez, J Heath, E González, A Wedin, M Prytz, D Asplund, E Haglind.   

Abstract

PURPOSE: Abdominoperineal resection (APR) for rectal cancer results in a permanent colostomy. As a consequence of a recent change in operative technique from standard (S-APR) to extralevator resection (E-APR), the perineal part of the procedure is now performed with the patient in a prone jackknife position. The impact of this change on stoma function is unknown. The aim was to determine stoma-related complications and the individual patient experience of a stoma.
METHODS: Consecutive patients with rectal cancer operated on with APR in one institution in 2004 to 2009 were included. Recurrent cancer, palliative procedures, pre-existing stoma and patients not alive at the start of the study were excluded. Data were collected from hospital records and the national colorectal cancer registry. A questionnaire was sent out to patients. The median follow-up was 44 months (13-84) after primary surgery.
RESULTS: Ninety-six patients were alive in February 2011. Seventy seven agreed to participate. Sixty-nine patients (90 %) returned the questionnaire. Stoma necrosis was more common for E-APR, 34 % vs. 10 %, but bandaging problems and low stoma height were more common for S-APR. There were no differences in the patients' experience of stoma function. In all, 35 % of the patients felt dirty and unclean, but 90 % felt that they had a full life and could engage in leisure activities of their choice.
CONCLUSIONS: This exploratory study indicates no difference in stoma function after 1 year between S-APR and E-APR. Over 90 % of the patients accept their stoma, but our study indicates that more information and support for patients are warranted.

Entities:  

Mesh:

Year:  2012        PMID: 22451254     DOI: 10.1007/s00384-012-1463-1

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  33 in total

1.  A population-based nationwide study of parents' perceptions of a questionnaire on their child's death due to cancer.

Authors:  Ulrika Kreicbergs; Unnur Valdimarsdóttir; Gunnar Steineck; Jan-Inge Henter
Journal:  Lancet       Date:  2004 Aug 28-Sep 3       Impact factor: 79.321

2.  Low rectal cancer: a call for a change of approach in abdominoperineal resection.

Authors:  Iris D Nagtegaal; Cornelius J H van de Velde; Corrie A M Marijnen; Jan H J M van Krieken; Philip Quirke
Journal:  J Clin Oncol       Date:  2005-12-20       Impact factor: 44.544

3.  Clinical and non-clinical factors influencing postoperative health-related quality of life in patients with colorectal cancer.

Authors:  T R Wilson; D J Alexander
Journal:  Br J Surg       Date:  2008-11       Impact factor: 6.939

Review 4.  Quality of life and sexual function following surgery for rectal cancer.

Authors:  S E Fisher; I R Daniels
Journal:  Colorectal Dis       Date:  2006-09       Impact factor: 3.788

5.  Quality of life after radical prostatectomy or watchful waiting.

Authors:  Gunnar Steineck; Fred Helgesen; Jan Adolfsson; Paul W Dickman; Jan-Erik Johansson; Bo Johan Norlén; Lars Holmberg
Journal:  N Engl J Med       Date:  2002-09-12       Impact factor: 91.245

6.  Mesorectal excision for rectal cancer.

Authors:  J K MacFarlane; R D Ryall; R J Heald
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

7.  Quality of life in rectal cancer patients: a four-year prospective study.

Authors:  Jutta Engel; Jacqueline Kerr; Anne Schlesinger-Raab; Renate Eckel; Hansjörg Sauer; Dieter Hölzel
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

8.  The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.

Authors:  Koen C M J Peeters; Corrie A M Marijnen; Iris D Nagtegaal; Elma Klein Kranenbarg; Hein Putter; Theo Wiggers; Harm Rutten; Lars Pahlman; Bengt Glimelius; Jan Willem Leer; Cornelis J H van de Velde
Journal:  Ann Surg       Date:  2007-11       Impact factor: 12.969

9.  The Swedish rectal cancer registry.

Authors:  L Påhlman; M Bohe; B Cedermark; M Dahlberg; G Lindmark; R Sjödahl; B Ojerskog; L Damber; R Johansson
Journal:  Br J Surg       Date:  2007-10       Impact factor: 6.939

10.  Quality of life among five-year survivors after treatment for very low rectal cancer with or without a permanent abdominal stoma.

Authors:  C Fucini; R Gattai; C Urena; L Bandettini; C Elbetti
Journal:  Ann Surg Oncol       Date:  2008-01-08       Impact factor: 5.344

View more
  14 in total

Review 1.  Comparison of short- and long-term outcomes after extralevator abdominoperineal excision and standard abdominoperineal excision for rectal cancer: a systematic review and meta-analysis.

Authors:  Hui-Chuan Yu; Hui Peng; Xiao-Sheng He; Ri-Sheng Zhao
Journal:  Int J Colorectal Dis       Date:  2013-11-23       Impact factor: 2.571

2.  Stoma-related symptoms in patients operated for rectal cancer with abdominoperineal excision.

Authors:  Adiela Correa Marinez; Elisabeth González; Kajsa Holm; David Bock; Mattias Prytz; Eva Haglind; Eva Angenete
Journal:  Int J Colorectal Dis       Date:  2016-01-05       Impact factor: 2.571

3.  The type of stoma matters-morbidity in patients with obstructing colorectal cancer.

Authors:  Adiela Correa-Marinez; Jacob Grenabo; David Bock; Anette Wedin; Eva Angenete
Journal:  Int J Colorectal Dis       Date:  2018-09-17       Impact factor: 2.571

4.  Short-term Outcomes of an Extralevator Abdominoperineal Resection in the Prone Position Compared With a Conventional Abdominoperineal Resection for Advanced Low Rectal Cancer: The Early Experience at a Single Institution.

Authors:  Seungwan Park; Hyuk Hur; Byung Soh Min; Nam Kyu Kim
Journal:  Ann Coloproctol       Date:  2016-02-29

5.  Extralevator Abdominoperineal Excision for Low Rectal Cancer--Extensive Surgery to Be Used With Discretion Based on 3-Year Local Recurrence Results: A Registry-based, Observational National Cohort Study.

Authors:  Mattias Prytz; Eva Angenete; David Bock; Eva Haglind
Journal:  Ann Surg       Date:  2016-03       Impact factor: 12.969

6.  Tumour-associated macrophages correlate with microvascular bed extension in colorectal cancer patients.

Authors:  Ilaria Marech; Michele Ammendola; Rosario Sacco; Giuseppe Sammarco; Valeria Zuccalà; Nicola Zizzo; Christian Leporini; Maria Luposella; Rosa Patruno; Gianfranco Filippelli; Emilio Russo; Mariangela Porcelli; Cosmo Damiano Gadaleta; Giovambattista De Sarro; Girolamo Ranieri
Journal:  J Cell Mol Med       Date:  2016-04-22       Impact factor: 5.310

7.  The effect of pre- and post-operative physical activity on recovery after colorectal cancer surgery (PHYSSURG-C): study protocol for a randomised controlled trial.

Authors:  Aron Onerup; Eva Angenete; David Bock; Mats Börjesson; Monika Fagevik Olsén; Elin Grybäck Gillheimer; Stefan Skullman; Sven-Egron Thörn; Eva Haglind; Hanna Nilsson
Journal:  Trials       Date:  2017-05-08       Impact factor: 2.279

8.  Persistent perineal morbidity is common following abdominoperineal excision for rectal cancer.

Authors:  Dan Asplund; Mattias Prytz; David Bock; Eva Haglind; Eva Angenete
Journal:  Int J Colorectal Dis       Date:  2015-08-06       Impact factor: 2.571

9.  Stoma-Const--the technical aspects of stoma construction: study protocol for a randomised controlled trial.

Authors:  Adiela Correa Marinez; Sofia Erestam; Eva Haglind; Jan Ekelund; Ulf Angerås; Jacob Rosenberg; Frederik Helgstrand; Eva Angenete
Journal:  Trials       Date:  2014-06-27       Impact factor: 2.279

10.  Correlation between serum tryptase, mast cells positive to tryptase and microvascular density in colo-rectal cancer patients: possible biological-clinical significance.

Authors:  Michele Ammendola; Rosario Sacco; Giuseppe Sammarco; Giuseppe Donato; Severino Montemurro; Eustachio Ruggieri; Rosa Patruno; Ilaria Marech; Marica Cariello; Angelo Vacca; Cosmo Damiano Gadaleta; Girolamo Ranieri
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.